These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

653 related items for PubMed ID: 25248955

  • 1. Clinical and demographic predictors of mild cognitive impairment for converting to Alzheimer's disease and reverting to normal cognition.
    Tokuchi R, Hishikawa N, Kurata T, Sato K, Kono S, Yamashita T, Deguchi K, Abe K.
    J Neurol Sci; 2014 Nov 15; 346(1-2):288-92. PubMed ID: 25248955
    [Abstract] [Full Text] [Related]

  • 2. Impact of white matter lesions and cognitive deficits on conversion from mild cognitive impairment to Alzheimer's disease.
    Defrancesco M, Marksteiner J, Deisenhammer E, Kemmler G, Djurdjevic T, Schocke M.
    J Alzheimers Dis; 2013 Nov 15; 34(3):665-72. PubMed ID: 23254639
    [Abstract] [Full Text] [Related]

  • 3. A comparative study: visual rating scores and the voxel-based specific regional analysis system for Alzheimer's disease on magnetic resonance imaging among subjects with Alzheimer's disease, mild cognitive impairment, and normal cognition.
    Li F, Takechi H, Saito R, Ayaki T, Kokuryu A, Kuzuya A, Takahashi R.
    Psychogeriatrics; 2019 Mar 15; 19(2):95-104. PubMed ID: 30276926
    [Abstract] [Full Text] [Related]

  • 4. Correlations between atrophy of the entorhinal cortex and cognitive function in patients with Alzheimer's disease and mild cognitive impairment.
    Li X, Jiao J, Shimizu S, Jibiki I, Watanabe K, Kubota T.
    Psychiatry Clin Neurosci; 2012 Dec 15; 66(7):587-93. PubMed ID: 23252925
    [Abstract] [Full Text] [Related]

  • 5. White matter disease independently predicts progression from mild cognitive impairment to Alzheimer's disease in a clinic cohort.
    Prasad K, Wiryasaputra L, Ng A, Kandiah N.
    Dement Geriatr Cogn Disord; 2011 Dec 15; 31(6):431-4. PubMed ID: 21757908
    [Abstract] [Full Text] [Related]

  • 6. An MRI brain atrophy and lesion index to assess the progression of structural changes in Alzheimer's disease, mild cognitive impairment, and normal aging: a follow-up study.
    Zhang N, Song X, Zhang Y, Chen W, D'Arcy RC, Darvesh S, Fisk JD, Rockwood K, Alzheimer's disease Neuroimaging Initiative.
    J Alzheimers Dis; 2011 Dec 15; 26 Suppl 3():359-67. PubMed ID: 21971475
    [Abstract] [Full Text] [Related]

  • 7. Correlating Cognitive Decline with White Matter Lesion and Brain Atrophy Magnetic Resonance Imaging Measurements in Alzheimer's Disease.
    Bilello M, Doshi J, Nabavizadeh SA, Toledo JB, Erus G, Xie SX, Trojanowski JQ, Han X, Davatzikos C.
    J Alzheimers Dis; 2015 Dec 15; 48(4):987-94. PubMed ID: 26402108
    [Abstract] [Full Text] [Related]

  • 8. IVIG treatment of mild cognitive impairment due to Alzheimer's disease: a randomised double-blinded exploratory study of the effect on brain atrophy, cognition and conversion to dementia.
    Kile S, Au W, Parise C, Rose K, Donnel T, Hankins A, Chan M, Ghassemi A.
    J Neurol Neurosurg Psychiatry; 2017 Feb 15; 88(2):106-112. PubMed ID: 26420886
    [Abstract] [Full Text] [Related]

  • 9. Predicting the conversion of mild cognitive impairment to Alzheimer's disease based on the volumetric measurements of the selected brain structures in magnetic resonance imaging.
    Nesteruk M, Nesteruk T, Styczyńska M, Barczak A, Mandecka M, Walecki J, Barcikowska-Kotowicz M.
    Neurol Neurochir Pol; 2015 Feb 15; 49(6):349-53. PubMed ID: 26652867
    [Abstract] [Full Text] [Related]

  • 10. Relation between subcortical grey matter atrophy and conversion from mild cognitive impairment to Alzheimer's disease.
    Yi HA, Möller C, Dieleman N, Bouwman FH, Barkhof F, Scheltens P, van der Flier WM, Vrenken H.
    J Neurol Neurosurg Psychiatry; 2016 Apr 15; 87(4):425-32. PubMed ID: 25904810
    [Abstract] [Full Text] [Related]

  • 11. Cognitive reserve and the risk for Alzheimer's disease: a longitudinal study.
    Serra L, Musicco M, Cercignani M, Torso M, Spanò B, Mastropasqua C, Giulietti G, Marra C, Bruno G, Koch G, Caltagirone C, Bozzali M.
    Neurobiol Aging; 2015 Feb 15; 36(2):592-600. PubMed ID: 25433459
    [Abstract] [Full Text] [Related]

  • 12. Montreal Cognitive Assessment Memory Index Score (MoCA-MIS) as a predictor of conversion from mild cognitive impairment to Alzheimer's disease.
    Julayanont P, Brousseau M, Chertkow H, Phillips N, Nasreddine ZS.
    J Am Geriatr Soc; 2014 Apr 15; 62(4):679-84. PubMed ID: 24635004
    [Abstract] [Full Text] [Related]

  • 13. Dynamics of brain structure and cognitive function in the Alzheimer's disease neuroimaging initiative.
    Song X, Mitnitski A, Zhang N, Chen W, Rockwood K, Alzheimer's Disease Neuroimaging Initiative.
    J Neurol Neurosurg Psychiatry; 2013 Jan 15; 84(1):71-8. PubMed ID: 23123510
    [Abstract] [Full Text] [Related]

  • 14. [Impact of combined medial temporal atrophy and white matter lesions on the cognitive and emotional functions in Alzheimer's disease patients].
    Tokuchi R, Deguchi K, Yamashita T, Abe K.
    Nihon Ronen Igakkai Zasshi; 2014 Jan 15; 51(4):342-9. PubMed ID: 25327368
    [Abstract] [Full Text] [Related]

  • 15. Varying strength of cognitive markers and biomarkers to predict conversion and cognitive decline in an early-stage-enriched mild cognitive impairment sample.
    Egli SC, Hirni DI, Taylor KI, Berres M, Regeniter A, Gass A, Monsch AU, Sollberger M.
    J Alzheimers Dis; 2015 Jan 15; 44(2):625-33. PubMed ID: 25322924
    [Abstract] [Full Text] [Related]

  • 16. Posterior Atrophy and Medial Temporal Atrophy Scores Are Associated with Different Symptoms in Patients with Alzheimer's Disease and Mild Cognitive Impairment.
    Hsu JL, Lee WJ, Liao YC, Lirng JF, Wang SJ, Fuh JL.
    PLoS One; 2015 Jan 15; 10(9):e0137121. PubMed ID: 26372372
    [Abstract] [Full Text] [Related]

  • 17. Association between executive dysfunction and hippocampal volume in Alzheimer's disease.
    Nagata T, Shinagawa S, Ochiai Y, Aoki R, Kasahara H, Nukariya K, Nakayama K.
    Int Psychogeriatr; 2011 Jun 15; 23(5):764-71. PubMed ID: 21106135
    [Abstract] [Full Text] [Related]

  • 18. Predicting conversion from mild cognitive impairment to Alzheimer's disease using brain 1H-MRS and volumetric changes: A two- year retrospective follow-up study.
    Mitolo M, Stanzani-Maserati M, Capellari S, Testa C, Rucci P, Poda R, Oppi F, Gallassi R, Sambati L, Rizzo G, Parchi P, Evangelisti S, Talozzi L, Tonon C, Lodi R, Liguori R.
    Neuroimage Clin; 2019 Jun 15; 23():101843. PubMed ID: 31071594
    [Abstract] [Full Text] [Related]

  • 19. Regional white matter lesions predict falls in patients with amnestic mild cognitive impairment and Alzheimer's disease.
    Ogama N, Sakurai T, Shimizu A, Toba K.
    J Am Med Dir Assoc; 2014 Jan 15; 15(1):36-41. PubMed ID: 24359699
    [Abstract] [Full Text] [Related]

  • 20. Utility of SPM8 plus DARTEL (VSRAD) combined with magnetic resonance spectroscopy as adjunct techniques for screening and predicting dementia due to Alzheimer's disease in clinical practice.
    Waragai M, Hata S, Suzuki T, Ishii R, Fujii C, Tokuda T, Arai H, Ohrui T, Higuchi S, Yoshida M, Igarashi K, Moriya M, Iwai N, Uemura K.
    J Alzheimers Dis; 2014 Jan 15; 41(4):1207-22. PubMed ID: 24787913
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.